This inventor holds 1 USPTO granted patent. Top assignee: Nanjing Nuoyuan Medical Devices Co., Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yang Luo and a Novel 99mTc-FAPI Diagnostic Probe
Introduction
Yang Luo is an inventor associated with Nanjing, China, and Nanjing Nuoyuan Medical Devices Co., Ltd. His patent work concerns a diagnostic probe designed to support tumor diagnosis.
Latest Patents
Luo is named on 1 patent: “Brand-new skeleton 99MTC-FAPI diagnostic probe and use thereof in preparation of drug or reagent for diagnosing tumors.” The disclosure describes a dimeric compound targeting FAP and its use in preparing a drug or reagent for diagnosing tumors. It reports that the technetium-99m-labeled compound has high tumor uptake, strong contrast between tumor and background, and favorable in vivo biodistribution compared with conventional FAP inhibitor radiopharmaceuticals.
Career Highlights
The available information connects Luo’s patent activity with Nanjing Nuoyuan Medical Devices Co., Ltd. His listed invention focuses on radiopharmaceutical probe design for tumor imaging and diagnosis.
Collaborations
Yueqing Gu and Zihan Wu are identified as Luo’s coworkers. The provided information does not specify their roles in the patent or their particular contributions.
Conclusion
Yang Luo’s listed patent centers on a novel technetium-99m-labeled FAP-targeting dimeric probe, with reported properties intended to improve tumor imaging and diagnostic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile